Pfizer, Bayer Clot Drugs Shown to Be Safe in Studies

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Aug. 31 (Bloomberg) -- Pfizer Inc. and Bayer AG revealed study results today that may give their medicines a foothold in a $10-billion-a-year market to prevent clots that cause strokes and deadly lung damage. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change